SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-17-002248
Filing Date
2017-04-21
Accepted
2017-04-21 16:01:25
Documents
11
Period of Report
2017-06-01
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042117.htm DEF 14A 501868
2 GRAPHIC logo.jpg GRAPHIC 32247
3 GRAPHIC greenleaf.jpg GRAPHIC 30767
4 GRAPHIC alder.jpg GRAPHIC 26829
5 GRAPHIC graph.jpg GRAPHIC 54841
6 GRAPHIC graph2.jpg GRAPHIC 21338
7 GRAPHIC graph3.jpg GRAPHIC 15926
8 GRAPHIC graph4.jpg GRAPHIC 53142
9 GRAPHIC graph5.jpg GRAPHIC 60669
10 GRAPHIC proxycard_1.jpg GRAPHIC 230845
11 GRAPHIC proxycard_2.jpg GRAPHIC 195620
  Complete submission text file 0001171843-17-002248.txt   1498503
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33609 | Film No.: 17775589
SIC: 2834 Pharmaceutical Preparations